Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309914085> ?p ?o ?g. }
- W4309914085 endingPage "251" @default.
- W4309914085 startingPage "236" @default.
- W4309914085 abstract "Semaphorin 3A (sema3A) is an osteoprotective factor that enhances bone formation while inhibiting osteoclast bone resorption. It is produced by rat calvarial osteoblasts cultured on grit-blasted/acid-etched microtextured (SLA) titanium surfaces at higher levels than on tissue culture polystyrene, suggesting that it may improve performance of titanium implants in vivo, particularly in conditions characterized by compromised bone quality. To test this, we established a clinically relevant type 2 diabetes mellitus (T2DM) rat model and used a non-toxic click hydrogel that rapidly polymerizes in situ (GEL) to provide localized controlled delivery of sema3A. In vitro studies confirmed that sema3A released from GEL was biologically active, increasing osteoblast differentiation of a pre-osteoblast cell-line. Whereas increased sema3A production was not observed in T2DM calvarial osteoblasts cultured on SLA, exogenous sema3A enhanced surface-induced osteoblast differentiation, indicating that it would be a viable candidate for in vivo use. Delivery of sema3A either by GEL or by local injection to bone defects enhanced osseointegration of SLA implants in the T2DM rats. Trabecular bone mass and bone-to-implant contact were decreased in T2DM rats compared to normal rats; sema3A delivered locally improved both parameters. These findings suggest that reduced trabecular bone contributes to poor osseointegration in T2DM patients and support GEL as a promising treatment option for sustained release of therapeutic doses of sema3A. Moreover, using this clinically translatable T2DM model and developing a biocompatible, Cu-free click chemistry hydrogel platform for the non-invasive delivery of therapeutics has major implications for regenerative medicine as a whole. STATEMENT OF SIGNIFICANCE: Osseointegration is compromised in patients with poor bone quality due to conditions like type 2 diabetes mellitus (T2DM). Previously, we showed that semaphorin 3A (sema3A) production is increased when human bone marrow stromal cells are cultured on titanium substrates that support osseointegration in vivo, suggesting it may enhance peri-implant osteogenesis in diabetes. Here we established a spontaneously developing T2DM rat model with clinical translatability and used it to assess sema3A effectiveness. Sema3A was delivered to the implant site via a novel copper-free click hydrogel, which has minimal swelling behavior and superior rheological properties. Osseointegration was successfully restored, and enhanced compared to burst release through injections. This study provides scientific evidence for using sema3A to treat impaired osseointegration in T2DM patients." @default.
- W4309914085 created "2022-11-30" @default.
- W4309914085 creator A5013266791 @default.
- W4309914085 creator A5029097051 @default.
- W4309914085 creator A5029880479 @default.
- W4309914085 creator A5052368052 @default.
- W4309914085 creator A5062107136 @default.
- W4309914085 creator A5084804911 @default.
- W4309914085 creator A5086565119 @default.
- W4309914085 date "2023-02-01" @default.
- W4309914085 modified "2023-09-30" @default.
- W4309914085 title "Semaphorin 3A delivered by a rapidly polymerizing click hydrogel overcomes impaired implant osseointegration in a rat type 2 diabetes model" @default.
- W4309914085 cites W1511719880 @default.
- W4309914085 cites W1563293563 @default.
- W4309914085 cites W160845983 @default.
- W4309914085 cites W1758660087 @default.
- W4309914085 cites W1767801721 @default.
- W4309914085 cites W1976265795 @default.
- W4309914085 cites W1982550559 @default.
- W4309914085 cites W2007241004 @default.
- W4309914085 cites W2007996527 @default.
- W4309914085 cites W2015859975 @default.
- W4309914085 cites W2018863954 @default.
- W4309914085 cites W2020267609 @default.
- W4309914085 cites W2020712539 @default.
- W4309914085 cites W2021236708 @default.
- W4309914085 cites W2023664549 @default.
- W4309914085 cites W2030869913 @default.
- W4309914085 cites W2039762060 @default.
- W4309914085 cites W2046800479 @default.
- W4309914085 cites W2050315451 @default.
- W4309914085 cites W2056415089 @default.
- W4309914085 cites W2057239555 @default.
- W4309914085 cites W2058919126 @default.
- W4309914085 cites W2064037967 @default.
- W4309914085 cites W2077730941 @default.
- W4309914085 cites W2080929032 @default.
- W4309914085 cites W2084103516 @default.
- W4309914085 cites W2099137703 @default.
- W4309914085 cites W2127839158 @default.
- W4309914085 cites W2130698995 @default.
- W4309914085 cites W2132989433 @default.
- W4309914085 cites W2144138736 @default.
- W4309914085 cites W2189356767 @default.
- W4309914085 cites W2308507491 @default.
- W4309914085 cites W2343842157 @default.
- W4309914085 cites W2414985918 @default.
- W4309914085 cites W2475005733 @default.
- W4309914085 cites W2520975622 @default.
- W4309914085 cites W2586409573 @default.
- W4309914085 cites W2614244966 @default.
- W4309914085 cites W2621576083 @default.
- W4309914085 cites W2767435144 @default.
- W4309914085 cites W2803499589 @default.
- W4309914085 cites W2887960110 @default.
- W4309914085 cites W2900521907 @default.
- W4309914085 cites W2900608028 @default.
- W4309914085 cites W2903038722 @default.
- W4309914085 cites W2903585911 @default.
- W4309914085 cites W2904555157 @default.
- W4309914085 cites W2906162767 @default.
- W4309914085 cites W2914886280 @default.
- W4309914085 cites W2915377991 @default.
- W4309914085 cites W2961845366 @default.
- W4309914085 cites W2964828861 @default.
- W4309914085 cites W2964947001 @default.
- W4309914085 cites W2972869264 @default.
- W4309914085 cites W2978728608 @default.
- W4309914085 cites W2990508316 @default.
- W4309914085 cites W2998999381 @default.
- W4309914085 cites W3003922479 @default.
- W4309914085 cites W3004850240 @default.
- W4309914085 cites W3015717458 @default.
- W4309914085 cites W3016876337 @default.
- W4309914085 cites W3035340459 @default.
- W4309914085 cites W3192767214 @default.
- W4309914085 cites W4289036783 @default.
- W4309914085 doi "https://doi.org/10.1016/j.actbio.2022.11.030" @default.
- W4309914085 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36435442" @default.
- W4309914085 hasPublicationYear "2023" @default.
- W4309914085 type Work @default.
- W4309914085 citedByCount "4" @default.
- W4309914085 countsByYear W43099140852023 @default.
- W4309914085 crossrefType "journal-article" @default.
- W4309914085 hasAuthorship W4309914085A5013266791 @default.
- W4309914085 hasAuthorship W4309914085A5029097051 @default.
- W4309914085 hasAuthorship W4309914085A5029880479 @default.
- W4309914085 hasAuthorship W4309914085A5052368052 @default.
- W4309914085 hasAuthorship W4309914085A5062107136 @default.
- W4309914085 hasAuthorship W4309914085A5084804911 @default.
- W4309914085 hasAuthorship W4309914085A5086565119 @default.
- W4309914085 hasConcept C101414908 @default.
- W4309914085 hasConcept C126322002 @default.
- W4309914085 hasConcept C132538176 @default.
- W4309914085 hasConcept C136229726 @default.
- W4309914085 hasConcept C141071460 @default.
- W4309914085 hasConcept C150903083 @default.
- W4309914085 hasConcept C170493617 @default.